RYH Invesco S&P 500 Equal Weight Health Care ETF
Quote as of Jun 12, 2025 13:42 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 287.42 | Day Range | 285.95 – 289.66 |
| 52-Week Range | 248.94 – 304.15 | Volume | 8.41K |
| Avg Volume | 8.12K | AUM | $960.7M (Oct 10, 2026) |
| Expense Ratio | 0.40% | Yield (TTM) | 0.06% |
| NAV | 29.14 | Premium/Discount | +885.11% indicative |
| Inception | Nov 01, 2006 | Holdings | 66 |
| Issuer | Invesco | Exchange | AMEX |
| Category | Healthcare | Index Tracked | S&P 500 |
| CUSIP | 46137V332 | ISIN | US46137V3327 |
| Management | Not stated in source data | ||
About this ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of all of the components of the S&P 500® Health Care Index, an index that contains the common stocks of all companies included in the S&P 500® Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard (GICS).
Description from the fund data provider · profile as of Oct 10, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | — | — | — | — | — | -52.53% | -33.31% | -15.70% | -2.85% |
| Total return | — | — | — | — | — | -52.46% | -33.24% | -15.51% | -2.67% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Jul 10, 2025. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.40% | Annual cost of a $10,000 investment | $40.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Oct 10, 2026 · portfolio reporting date from the data provider; holdings are not live positions. 65 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 2.67% | 105.59K | $23.8M |
| 2 | Illumina Inc | ILMN | 2.18% | 69.86K | $19.4M |
| 3 | Revvity Inc | PKI | 2.00% | 115.59K | $17.8M |
| 4 | Mettler-Toledo International Inc | MTD | 1.93% | 11.10K | $17.2M |
| 5 | Intuitive Surgical Inc | ISRG | 1.93% | 40.53K | $17.2M |
| 6 | Agilent Technologies Inc | A | 1.90% | 98.93K | $16.9M |
| 7 | Veeva Systems Inc | VEEV | 1.83% | 54.93K | $16.3M |
| 8 | AbbVie Inc | ABBV | 1.77% | 57.07K | $15.8M |
| 9 | Thermo Fisher Scientific Inc | TMO | 1.75% | 23.64K | $15.6M |
| 10 | West Pharmaceutical Services Inc | WST | 1.75% | 42.50K | $15.6M |
| 11 | Charles River Laboratories International Inc | CRL | 1.74% | 51.40K | $15.5M |
| 12 | Humana Inc | HUM | 1.73% | 35.76K | $15.4M |
| 13 | Danaher Corp | DHR | 1.73% | 69.93K | $15.4M |
| 14 | Waters Corp | WAT | 1.72% | 35.38K | $15.3M |
| 15 | Biogen Inc | BIIB | 1.72% | 67.90K | $15.3M |
| 16 | Viatris Inc | VTRS | 1.72% | 867.97K | $15.3M |
| 17 | HCA Healthcare Inc | HCA | 1.72% | 33.90K | $15.3M |
| 18 | Amgen Inc | AMGN | 1.70% | 36.59K | $15.2M |
| 19 | McKesson Corp | MCK | 1.69% | 16.05K | $15.1M |
| 20 | Eli Lilly & Co | LLY | 1.68% | 12.71K | $15.0M |
| 21 | ResMed Inc | RMD | 1.68% | 65.13K | $15.0M |
| 22 | Elevance Health Inc | ANTM | 1.67% | 36.03K | $14.9M |
| 23 | Gilead Sciences Inc | GILD | 1.67% | 98.27K | $14.9M |
| 24 | Becton Dickinson & Co | BDXA | 1.64% | 79.66K | $14.6M |
| 25 | Centene Corp | CNC | 1.64% | 223.55K | $14.6M |
| 26 | Zoetis Inc | ZTS | 1.64% | 195.11K | $14.6M |
| 27 | Pfizer Inc | PFE | 1.64% | 514.95K | $14.6M |
| 28 | Cigna Group/The | CI | 1.63% | 51.44K | $14.5M |
| 29 | IQVIA Holdings Inc | IQV | 1.63% | 55.76K | $14.5M |
| 30 | Universal Health Services Inc | UHS | 1.62% | 81.40K | $14.4M |
| 31 | GE HealthCare Technologies Inc | GEHC | 1.62% | 219.51K | $14.4M |
| 32 | Stryker Corp | SYK | 1.62% | 51.95K | $14.4M |
| 33 | IDEXX Laboratories Inc | IDXX | 1.62% | 27.81K | $14.4M |
| 34 | Dexcom Inc | DXCM | 1.61% | 170.72K | $14.4M |
| 35 | Bio-Techne Corp | TECH | 1.61% | 198.01K | $14.3M |
| 36 | Cencora Inc | COR | 1.61% | 44.28K | $14.3M |
| 37 | Baxter International Inc | BAX | 1.60% | 586.52K | $14.3M |
| 38 | STERIS PLC | STE | 1.60% | 66.50K | $14.3M |
| 39 | Edwards Lifesciences Corp | EW | 1.59% | 166.17K | $14.2M |
| 40 | Cardinal Health Inc | CAH | 1.59% | 59.60K | $14.2M |
| 41 | Merck & Co Inc | MRK | 1.59% | 97.10K | $14.1M |
| 42 | Insulet Corp | PODD | 1.58% | 103.85K | $14.0M |
| 43 | Quest Diagnostics Inc | DGX | 1.58% | 60.79K | $14.0M |
| 44 | Vertex Pharmaceuticals Inc | VRTX | 1.58% | 27.50K | $14.0M |
| 45 | Johnson & Johnson | JNJ | 1.57% | 53.63K | $14.0M |
| 46 | DaVita Inc | DVA | 1.57% | 78.16K | $14.0M |
| 47 | Labcorp Holdings Inc | LH | 1.56% | 44.62K | $13.9M |
| 48 | Solventum Corp | SOLV | 1.56% | 158.89K | $13.9M |
| 49 | UnitedHealth Group Inc | UNH | 1.55% | 36.38K | $13.8M |
| 50 | Medtronic PLC | MDT | 1.55% | 155.80K | $13.8M |
| 51 | Henry Schein Inc | HSIC | 1.53% | 162.62K | $13.7M |
| 52 | Boston Scientific Corp | BSX | 1.53% | 318.16K | $13.6M |
| 53 | Abbott Laboratories | ABT | 1.52% | 135.92K | $13.5M |
| 54 | Zimmer Biomet Holdings Inc | ZBH | 1.51% | 151.20K | $13.5M |
| 55 | Align Technology Inc | ALGN | 1.50% | 93.56K | $13.4M |
| 56 | Regeneron Pharmaceuticals Inc | REGN | 1.49% | 17.72K | $13.2M |
| 57 | Bristol-Myers Squibb Co | BMY | 1.48% | 222.14K | $13.1M |
| 58 | CVS Health Corp | CVS | 1.45% | 149.97K | $12.9M |
| 59 | Incyte Corp | INCY | 1.44% | 113.53K | $12.8M |
| 60 | Cooper Cos Inc/The | COO | 1.38% | 225.34K | $12.3M |
| 61 | USD Pending Dividends | — | 0.05% | 0 | $482.9K |
| 62 | Invesco Government & Agency Portfolio | AGPXX | 0.02% | 207.13K | $207.1K |
| 63 | TPG Inc 12/31/2030 | — | 0.00% | 162.79K | $0.00 |
| 64 | SECURITIES LENDING - BNYM | — | 0.00% | 1 | $0.01 |
| 65 | CASH & EQUIVALENTS | — | 0.00% | -0 | -$0.01 |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 0.06% | Paid (last 12 months) | $0.1718 |
| Frequency | Quarterly | SEC yield | Not provided by our data source; see the issuer page |
| Last ex-date | Jun 22, 2026 | Last payment | $0.0627 |
| Growth 1Y | -24.41% | Growth 3Y / 5Y (ann.) | -3.82% / +4.80% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 22, 2026 | — | — | $0.0627 |
| Mar 23, 2026 | — | — | $0.0561 |
| Dec 22, 2025 | — | — | $0.0530 |
| Sep 22, 2025 | — | — | $0.0599 |
| Jun 23, 2025 | — | — | $0.0555 |
| Mar 24, 2025 | — | — | $0.0551 |
| Dec 23, 2024 | — | — | $0.0569 |
| Sep 23, 2024 | — | — | $0.0547 |
| Jun 24, 2024 | — | — | $0.0508 |
| Mar 18, 2024 | — | — | $0.0459 |
| Dec 18, 2023 | — | — | $0.0499 |
| Sep 18, 2023 | — | — | $0.0479 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
Liquidity
| Volume today | 8.41K | Average volume | 8.12K |
| AUM | $960.7M | Premium/Discount | +885.11% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV: an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source; review them before investing.
Latest News for RYH
No articles mention this fund directly in the last 7 days; showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.